Duration of High-Dose Interferon Alfa-2b Regimen for Resected High-Risk Melanoma

被引：2
作者：
Agarwala, Sanjiv S. [1 ,2 ]
Gray, Robert J. [3 ,4 ]
Wong, Michael K. K. [5 ]
机构：
[1] Univ Penn, Philadelphia, PA 19104 USA
[2] St Lukes Canc Ctr, Bethlehem, PA USA
[3] Dana Farber Canc Inst, Boston, MA 02115 USA
[4] Harvard Univ, Boston, MA 02115 USA
[5] GU Clin Roswell Pk Canc Inst, Buffalo, NY USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2009年 / 27卷 / 25期
关键词：
ADJUVANT THERAPY; TRIAL;
D O I：
10.1200/JCO.2009.23.0334
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：E82 / E83
页数：2
相关论文
共 6 条
  • [1] Gefitinib for recurrent non-small-cell lung cancer: All things are not created equal
    Dahlberg, Suzanne E.
    Gray, Robert J.
    Johnson, Bruce E.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (26) : 4233 - 4235
  • [2] Post-surgery adjuvant therapy with intermediate doses of interferon alfa 2b versus observation in patients with stage IIb/III melanoma (EORTC 18952): randomised controlled trial
    Eggermont, AMM
    Suciu, S
    MacKie, R
    Ruka, W
    Testori, A
    Kruit, W
    Punt, CJA
    Delauney, M
    Sales, F
    Groenewegen, G
    Ruiter, DJ
    Jagiello, I
    Stoitchkov, K
    Keilholz, U
    Lienard, D
    [J]. LANCET, 2005, 366 (9492) : 1189 - 1196
  • [3] *GUID IND, 2001, E 10 CHOIC CONTR GRO
  • [4] High- and low-dose interferon alfa-2b in high-risk melanoma: First analysis of Intergroup Trial E1690/S9111/C9190
    Kirkwood, JM
    Ibrahim, JG
    Sondak, VK
    Richards, J
    Flaherty, LE
    Ernstoff, MS
    Smith, TJ
    Rao, U
    Steele, M
    Blum, RH
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (12) : 2444 - 2458
  • [5] Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: The Eastern Cooperative Oncology Group trial EST 1684
    Kirkwood, JM
    Strawderman, MH
    Ernstoff, MS
    Smith, TJ
    Borden, EC
    Blum, RH
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (01) : 7 - 17
  • [6] Randomized Phase III Study of 1 Month Versus 1 Year of Adjuvant High-Dose Interferon Alfa-2b in Patients With Resected High-Risk Melanoma
    Pectasides, Dimitrios
    Dafni, Urania
    Bafaloukos, Dimitrios
    Skarlos, Dimosthenis
    Polyzos, Aristidis
    Tsoutsos, Dimosthenis
    Kalofonos, Haralambos
    Fountzilas, George
    Panagiotou, Petros
    Kokkalis, George
    Papadopoulos, Othon
    Castana, Ourania
    Papadopoulos, Stefanos
    Stavrinidis, Elias
    Vourli, Georgia
    Ioannovich, John
    Gogas, Helen
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (06) : 939 - 944
1